NovaBay Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of NBY for the last quarter is 2.40 M USD, and it's 8.78% lower compared to the previous quarter. The net income of Q2 24 is -1.58 M USD.